0000051143 false --12-31 Capital stock, par value $.20 per share IBM CHX 0000051143 2020-12-15 2020-12-15 0000051143 us-gaap:CommonStockMember exch:XCHI 2020-12-15 2020-12-15 0000051143 us-gaap:CommonStockMember exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.500PercentDue2021Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes2.625PercentDue2022Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.25PercentDue2023Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.375PercentDue2023Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.125PercentDue2024Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes2.875PercentDue2025Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2020-12-15 2020-12-15 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2020-12-15 2020-12-15 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2020-12-15 2020-12-15 0000051143 ibm:Debentures7.00PercentDue2025Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2020-12-15 2020-12-15 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2020-12-15 2020-12-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

Title of each class
Trading symbol

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report: December 15, 2020

(Date of earliest event reported)

 

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York   1-2360   13-0871985
(State of Incorporation)   (Commission File Number)   (IRS employer Identification No.)

 

One New Orchard Road

 
Armonk, New York 10504
(Address of principal executive offices) (Zip Code)

 

914-499-1900

(Registrants telephone number)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange
on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
        NYSE Chicago
0.500% Notes due 2021   IBM 21B   New York Stock Exchange
2.625% Notes due 2022   IBM 22A   New York Stock Exchange
1.250% Notes due 2023   IBM 23A   New York Stock Exchange
0.375% Notes due 2023   IBM 23B   New York Stock Exchange
1.125% Notes due 2024   IBM 24A   New York Stock Exchange
2.875% Notes due 2025   IBM 25A   New York Stock Exchange
0.950% Notes due 2025   IBM 25B   New York Stock Exchange
0.875% Notes due 2025   IBM 25C   New York Stock Exchange
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
7.00% Debentures due 2025   IBM 25   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02(b) Departure of Named Executive Officer and Item 5.02(e) Compensatory Arrangement for Named Executive Officer.

 

On December 15, 2020, Dr. John E. Kelly III, Executive Vice President, age 66, decided to retire from the Company on December 31, 2020, after a more than 40-year career with IBM.

 

After Dr. Kelly’s retirement from the company, he may be asked, from time to time, to provide services to the company as an independent contractor. The fee for such services would be $7,800 per day for each day he provides four or more hours of services and $3,900 per day for each day that he provides less than four hours.

 

The consulting arrangement is set forth in the Letter attached as Exhibit 99.1.

 

Item 5.03(a) Amendment to Bylaws.

 

On December 15, 2020, the IBM Board of Directors adopted amendments to IBM’s By-laws, effective January 1, 2021, to (i) amend Article III, Section 2, to decrease the number of directors from fourteen to thirteen as a result of the previously disclosed retirement of Virginia M. Rometty, (ii) add Article III, Section 11 to permit stockholders to remove a director, with or without cause, at any time, by a vote of the stockholders and (iii) make a few minor changes throughout the By-Laws to clarify the Vice Chairman officer position.

 

The foregoing description of the amendments to the By-laws is qualified in its entirety by the text of the By-laws, a copy of which is attached hereto as Exhibit 3.2 and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibits are being filed as part of this report:

 

Exhibit No.   Description of Exhibit
3.2    The By-laws of IBM, as amended through January 1, 2021
     
99.1   Letter
     

104

 

Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date: December 18, 2020  
   
  By: /s/ Frank Sedlarcik
    Frank Sedlarcik
    Vice President, Assistant General Counsel and Secretary

 

3